The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

The Health Ministry has launched investigations into the rising misuse of Ozempic, which is a diabetes drug, that Kenyans are ...

How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study ...